A study on seroprevalence of hepatotropic viruses among HIV-positive individuals attending the integrated counselling and testing centre (ICTC) in Mayo hospital of Nagpur city, Maharashtra, India

Nikita Sherwani, R. K. Khadse, Dhiraj Bhawnani, Nirmal Verma


Background: Infection with human immunodeficiency virus type-1 and its end stage, acquired immunodeficiency syndrome is the major public health challenge of modern time. A variety of exogenously acquired infectious agents appear to influence the pace of HIV replication, the destruction of CD4+ T cells, and HIV transmission to infants and sexual partners. More persistent elevations in plasma HIV levels have been seen in patients with chronic infections (such as those with tuberculosis and herpes and hepatitis viruses), and such co-infected patients have a more rapid loss of CD4+ T cells and an increased rate of progression to AIDS and death. Within India, variable co-infection rates have been reported from region to region. With the above background, the present study was undertaken to study the seroprevalence of hepatotropic viruses (Hepatitis B virus and Hepatitis C virus) in HIV-positive individuals attending the Integrated Counselling and Testing Centre (ICTC) in Mayo hospital of Nagpur city, Maharashtra, India.  

Methods: The current prospective study was conducted in the department of microbiology, Indira Gandhi government medical college and Mayo general hospital, Nagpur (Maharashtra) from August 2005 to August 2007. All the patients attending ICTC were included in the study. 300 HIV negative matched controls were also included in the study. All the individuals who were positive for HIV infection were selected for this study and further tested for the presence of hepatitis B surface antigen (HBsAg) and anti-HCV antibodies. Data was compiled in MS excel. Then it was analyzed using online statistical calculator and chi square test were applied with value of P <0.05 was considered statistically significant for interpretation of finding.  

Results: Maximum numbers of HIV positive patients (38.8%) were in age group of 31-40 years. Present study showed male preponderance in HIV positive patients. Males showed a slightly high seroprevalence of HBsAg (9.21%) compared to females (7.57%) among HIV positive patients. The difference in positivity of two viral agents studied in HIV positive patients was highly significant as compared to HIV-negative individuals (P <0.001).  

Conclusion: On the basis of the findings that the co-infection of hepatotropic viruses (HBV and HCV) were significantly higher in HIV positive cases than controls, the study concludes that the chronic viral hepatitis is a serious concern in HIV-infected patients. Thus, there is an urgent need to ensure the screening of the same in HIV-infected patients.



Co-infection, Hepatitis B virus, Hepatitis C virus, HIV, Maharashtra, Nagpur city

Full Text:



Cleghorn FR, Reitz MS, Popovic M, Gallo RC. Human immunodeficiency viruses. In: Mandell GL, Bennett JE, Dolin R eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Churchill Livingstone; 2005: 2119-2133.

UNAIDS/WHO. Joint United Nations Programme on HIV/AIDS. In: WHO, eds. AIDS Epidemic Update. Geneva: WHO; December 2006: 1-86.

Corey L. Synergistic co-pathogens - HIV-I and HSV-2. N Engl J Med. 2007;356:854-6.

Toosi Z, Mayanja-Kizza H, Hirsch CS, Edmonds KL, Spahlinger T, Hom DL, et al. Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol. 2001;123:233-8.

Chung RT, Kim AY, Polsky B. HIV/hepatitis B and C co-infection: pathogenic interaction, natural history & therapy. Antivir Chem Chemother. 2001;12(Suppl 1):73-91.

Soriano V, Garcia-Samaniego J, Valencia E, Rodriquez-Rosado R, Muñoz F, González-Lahoz J. Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV infected drug users. Eur J Epidemiol. 1999;15:1-4.

McCarron B, Thyagarajan SP. HIV and hepatotropic viruses: interactions and treatment. Indian J Med Microbiol. 1998;16(1):4-11.

Gupta S, Singh S. Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients. World J Gastroenterol. 2006;12(42):6879-83.

Sungkanuparph S, Vibhagool A, Monosuthi W, Kiertiburanakul S, Atamasirikul K, Aumkhyan A, et al. Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary care based study. J Med Assoc Thai. 2004;87(11):1349-54.

Tankhiwale SS, Khadse RK, Jalgaonkar SV. Sero-prevalence of anti HCV and hepatitis B surface antigen in HIV infected patients. Indian J Med Microbiol. 2003;21:268-70.

Ockenga J, Tillman HL, Trautwein C, Stoll M, Manns MP, Schmidt RE. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol. 1997;27(1):18-24.

Piroth L, Duong M, Quantin C, Abrahamowicz M, Michardiere R, Aho LS, et al. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS. 1998;12:381-8.

Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatic. 2006;44:56-9.

Kumaraswamy N, Solomon S, Flanigen TP, Hemlatha R, Thyagarajan SP, Mayer KH. Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis. 2003;36:79-85.

Rathi PM, Amarapurkar DN, Borges NE, Koppikar GV, Kalro RH. Spectrum of liver disease to HIV infection. Indian J Gastroenterol. 1997;16:94-5.

NACO: National AIDS Control Organisation. An over view of the spread and prevalence of HIV/ AIDS in India. In: NACO, eds. An Overview. New Delhi: NACO; 2005(a).

Park K. Viral hepatitis. In: Park K, eds. Park’s Textbook of Preventive and Social Medicine. 18th ed. Jabalpur: M/S Banarsidas Bhanot Publishers; 2005: 167-175.

Gupta V, Singla N, Lehl SS, Chander J. Clinico- epidemiological profile of HIV infection over a period of six years in a North Indian tertiary care hospital. Indian J Med Microbiol. 2007;25(2):171-8.

Kumaraswamy N, Vallabhaneni S, Flanigan TP, Mayer K, Solomon S. Clinical profile of HIV in India. Indian J Med Res. 2005;121:377-94.

Lawn SD. AIDS in Africa: the impact of co-infection on the pathogenesis of HIV-I infection. J Infect Dis. 2004;48(1):1-12.

Anvikar AR, Chakma T, Rao VG. HIV epidemic in central India: trends over 18 years (1986-2003). Actatropica. 2005;93(3):289-94.

Sharma SK, Kadhiravan T, Banga A, Goyal T, Bhatia I, Saha PK. Spectrum of clinical disease in a series of 135 hospitalized HIV-infected patients from North India. BMC Infect Dis. 2004;4:52.

Saravanan S, Velu V, Kumarasamy N, Nadakumar S, Murugavel KG, Balakrishnan P, et al. Co-infection of hepatitis B and hepatitis C virus in HIV-infected patients in south India. World J Gastroenterol. 2007;13(37):5015-20.

Chalasani N, Wilcox CM. Etiology, evaluation, and outcome of jaundice in patients with acquired immunodeficiency syndrome. Hepatology. 1996;23:728-35.

Padmapriyadarsini C, Chandrabose J, Victor L, Hanna LE, Arunkumar N, Swaminathan S. Hepatitis B or hepatitis C co-infection in individual infected with human immunodeficiency virus and effect of anti- tuberculosis drugs on liver function. J Postgrad Med. 2006;52:92-6.

Tripathi AK, Khanna M, Gupta N, Chandra M. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India. J Assoc Physicians India. 2007;55:429-31.

Gale MJ, Blakely CM, Kwieciszewski B, Tan SL, Dossett M, Tang NM, et al. Control of PKR protein kinase by the hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase recognition. Mol Cell Biol. 1998;18:5208-18.

Spengler U, Rockstroh JK. Hepatitis C in the patient with human immunodeficiency virus infection. J Hepatol. 1998;29:1023-30.

Lesi OA, Kehinde MD, Oguh DN, Amira CO. Hepatitis B and C virus infection in Nigerian patients with HIV/AIDS. Niger Postgrad Med. 2007;14(2):129-33.

Combe P, La Ruche G, Bonard D, Ouassa T, Faye-Kette YA, Sylla-Koko F, et al. Hepatitis B and C infections, human immunodeficiency virus and other sexually transmitted infections among women of childbearing age in Cote d’Ivoire, West Africa. Trans R Soc Trop Med Hyg. 2001;95(5):493-6.

Saha MK, Chakrabarti S, Panda S, Naik TN, Manna B, Chatterjee A, et al. Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India. Indian J Med Res. 2000;111:37-9.

Abraham P, John TJ. Hepatitis C: a review with particular reference to the Indian scenario. Indian J Med Microbiol. 1995;13:5-14.

Dienstag JL, Isselbacher KJ. Acute viral hepatitis. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL eds. Harrison’s Principle of Internal Medicine. 16th ed. New York: McGraw Hill; 2005: 1822-1837.

Kim O, Kim SS, Park MS, Suh SD, Lee MW, Kim KS, et al. Seroprevalence of sexually transmitted viruses in Korean populations including HIV-seropositive individuals. Int J STD AIDS. 2003;14(1):46-9.

Rivas-Estilla AM, Ramirez-Valles E, Martinez-Hernandez R, Charles-Niño C, Ramírez-Camacho E, Rositas-Noriega F, et al. Hepatitis C virus infection among HIV-1 infected individuals from Northern Mexico. Hepatol Res. 2007;37(5):311-6.

Jaroszewicz J, Reiberger T, Meyer-Olson D, Mauss S, Vogel M, Ingiliz P, et al. Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection. PLoS One. 2012;7(8):e43143.

Shen Y, Wang Z, Qi T, Jiang X, Song W, Tang Y, et al. Serological survey of viral hepatitis markers among newly diagnosed patients with HIV/AIDS in China. HIV Med. 2013;14:167-75.